BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19000558)

  • 21. Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers.
    Neves R; Almeida S; Filipe A; Spínola AC; Abolfathi Z; Yritia M; Ortuño J
    Arzneimittelforschung; 2008; 58(8):369-75. PubMed ID: 18807576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Antonijoan R; García-Gea C; Gich I; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):59-63. PubMed ID: 16572918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus.
    Stockis A; Hartstra J; Mollet M; Hadi S
    Epilepsia; 2016 Aug; 57(8):1288-93. PubMed ID: 27346728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of two formulations of escitalopram.
    Almeida S; Pedroso P; Filipe A; Neves RI; Tanguay M; Torns A
    Arzneimittelforschung; 2012 Jul; 62(7):307-12. PubMed ID: 22628062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Truncated AUC in the evaluation of fluconazole bioequivalence. A cross-over, randomised, open-label study in healthy volunteers.
    Portolés A; Almeida S; Terleira A; de Pablo I; Filipe A; Cruz Caturla M; Moreno A
    Arzneimittelforschung; 2004; 54(11):752-6. PubMed ID: 15612616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of a novel minitablet formulation of levetiracetam.
    de Mey C; Dimitrova V; Lennartz P; Wangemann M
    Arzneimittelforschung; 2012 Feb; 62(2):94-8. PubMed ID: 22344554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative bioavailability/ bioequivalence of two different sertraline formulations: a randomised, 2-period x 2-sequence, crossover clinical trial in healthy volunteers.
    Almeida S; Portolés A; Terleira A; Filipe A; Cea E; Caturla MC
    Arzneimittelforschung; 2005; 55(4):191-7. PubMed ID: 15901041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers.
    Portolés A; Filipe A; Almeida S; Terleira A; Vallée F; Vargas E
    Arzneimittelforschung; 2005; 55(4):212-7. PubMed ID: 15901044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence study of two tablet formulations of ramipril in healthy volunteers.
    Allegrini A; Nuzzo L; Zucchelli M; Tavella-Scaringi A; Bucci M; Pavone D; Toniato E; Mezzetti A; Martinotti S; Bonani S
    Arzneimittelforschung; 2009; 59(8):392-6. PubMed ID: 19813461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.
    Almeida S; Filipe A; Neves R; Spínola AC; Tanguay M; Ortuño J; Farré A; Torns A
    Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers.
    Cánovas M; Arcabell M; Martínez G; Canals M; Cabré F
    Arzneimittelforschung; 2011; 61(11):610-6. PubMed ID: 22232849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers.
    De Gregori S; Cipollina L; De Silvestri A; Ventura M; Michelini R; Morosini M; Montagna M; Tinelli C; Regazzi M; Molinaro M; Imberti R
    Ther Drug Monit; 2017 Apr; 39(2):118-123. PubMed ID: 28196046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bioavailability of two ramipril formulations after single-dose administration in healthy volunteers.
    Mendes GD; Dantas Sanfelice AT; do Carmo Borges NC; Cavedal LE; Sverdloff C; Prado Galuppo M; Módolo JH; De Nucci G
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):93-8. PubMed ID: 16502769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of two clopidogrel film-coated tablet formulations in healthy volunteers.
    Setiawati E; Yunaidi DA; Handayani LR; Santoso ID; Setiawati A; Tjandrawinata RR
    Arzneimittelforschung; 2011; 61(12):681-4. PubMed ID: 22282954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and bioequivalence study of etoricoxib tablet in healthy Bangladeshi volunteers.
    Shohag MH; Islam MS; Ahmed MU; Joti JJ; Islam MS; Hasanuzzaman M; Hasnat A
    Arzneimittelforschung; 2011; 61(11):617-21. PubMed ID: 22232850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence studies for two different strengths of montelukast in healthy volunteers: 10 mg film-coated tablets and 5 mg chewable tablets.
    Pedroso P; Almeida S; Filipe A; Neves RI; Boudreault S; Jiménez C
    Drug Res (Stuttg); 2013 Sep; 63(9):477-83. PubMed ID: 23780502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic evaluation of immediate- and extended-release formulations of levetiracetam in dogs.
    Boozer LB; Platt SR; Haley AC; Linville AV; Kent M; Barron LE; Nie B; Arnold RD
    Am J Vet Res; 2015 Aug; 76(8):719-23. PubMed ID: 26207970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.